Agno Pharmaceuticals is a U.S.-headquartered global end-to-end CDMO providing comprehensive solutions from API development and intermediates through complex drug product formulation to cGMP manufacturing for both clinical trials and commercial production. The company supports both innovative and generic pharmaceutical sectors with capabilities in small molecule APIs, highly potent APIs (HPAPIs), sterile APIs, and drug products.
Small molecule API manufacturing, HPAPIs, sterile APIs, drug product formulation, clinical and commercial cGMP manufacturing, regulatory starting materials, intermediates
2 sites worldwide
Involvement in 20 clinical trials
No reviews available yet.
No documents available.